Knowingly. The term “knowingly” as used in this Agreement means actual knowledge or reasonable reason to suspect. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
Appears in 2 contracts
Samples: Distribution and Sublicense Agreement (Braeburn Pharmaceuticals, Inc.), Distribution and Sublicense Agreement (Braeburn Pharmaceuticals, Inc.)
